Cart
sales@molnova.com
Substance P, Free Acid
CAS No. 71977-09-8
Substance P, Free Acid( —— )
Catalog No. M30486 CAS No. 71977-09-8
Substance P, Free Acid is a native substance P analog, but shows no biological activity of substance P.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 81 | Get Quote |
|
| 10MG | 138 | Get Quote |
|
| 25MG | 279 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSubstance P, Free Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionSubstance P, Free Acid is a native substance P analog, but shows no biological activity of substance P.
-
DescriptionSubstance P, Free Acid is a native substance P analog, but shows no biological activity of substance P.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number71977-09-8
-
Formula Weight1348.61
-
Molecular FormulaC63H97N17O14S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
EC5026
EC5026 has the potential to relieve pain by stabilizing natural analgesic and anti-inflammatory mediators.?EC5026 (BPN-19186) is a first-in-class, small molecule that potently inhibits soluble Epoxide Hydrolase (sEH), a key regulatory enzyme involved in the metabolism of membrane fatty acids.?Inhibition of sEH treats pain by stabilizing natural analgesic and anti-inflammatory mediators.
-
ACTH (18-39), human
Adrenocorticotropic Hormone (ACTH) (18-39) is known as the Corticotropin-like Intermediate Lobe Peptide. It stimulates insulin secretion as well as amylase and protein secretion in a dose-dependent manner similar to those of secretin and carbamylcholine.
-
S107
S107 is a RyR-selective 1, 4-benzothiazepine derivative that stabilizes RyR2 channels by enhancing the binding affinity of calstabin2 to mutant and/or PKA-phosphorylated channels.
